Screening Cuts Ovarian Cancer Mortality.
Based on a study that began in 2001, researchers have concluded that ovarian cancer screening increases survival. Disease-related mortality was 20% lower among women who received multimodal screening-annual testing of CA125 blood levels and, if CA125 was abnormal, additional CA125 tests and perhaps transvaginal ultrasound-than among those who weren't screened. When researchers factored in the delayed benefits of screening, the mortality reduction was 22%.